This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H10N7 Hemagglutinin (HA), N-His
Product Overview
BioVenic's Recombinant Influenza A H10N7 Hemagglutinin (HA), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 25.9 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Hemagglutinin (HA) is a vital surface glycoprotein of the Influenza A virus (H10N7) responsible for viral entry. It mediates binding to host cell sialic acid receptors and facilitates the fusion of the viral envelope with the endosomal membrane. As a primary target for neutralizing antibodies, HA is critical for vaccine development and antiviral research. The H10N7 subtype specifically characterizes avian influenza strains that occasionally cross the species barrier to infect mammals and humans.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.